TME Pharma announces completion of share consolidation
TME Pharma N.V., (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announced today the amendment of the Articles of Association effecting the share consolidation such that Mehr